ARELI TORRES: Open Payments
NPI 1043223704 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 29 payments from 10 companies in 2025. Trend: 2023 $399 · 2024 $549 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $303 |
| Amgen Inc. | 4 | $109 |
| Lilly USA, LLC | 4 | $83 |
| PFIZER INC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Wegovy, MOUNJARO, OTEZLA, PREVNAR 20, Ozempic, JARDIANCE, EVENITY, BOTOX.
Industry payments across CA — which companies pay providers there.
